Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Definition of Radiological and Endocrine/metabolic/inflammatory Biomarker(s) to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

NCT06706700 is registered in ClinicalTrials.gov with IRCCS San Raffaele as lead sponsor.

NCT NCT06706700
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06706700 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Definition of Radiological and Endocrine/metabolic/inflammatory Biomarker(s) to Identify Highgrade Dysplasia/invasive Carcinoma in Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas
Lead sponsor
IRCCS San Raffaele
Phase
Observational
Overall status
Recruiting
Start date
July 13, 2020
Completion date
March 31, 2025
Enrollment
586 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

intraductal papillary mucinous neoplasm of pancreas, pancreatic cyst